Co-Authors
This is a "connection" page, showing publications co-authored by Nassim Kamar and Olivier Marion.
Connection Strength
2.503
-
Safety and Immunogenicity of Anti-SARS-CoV-2 Messenger RNA Vaccines in Recipients of Solid Organ Transplants. Ann Intern Med. 2021 09; 174(9):1336-1338.
Score: 0.947
-
Anti-SARS-CoV-2 Monoclonal Antibodies in Solid-organ Transplant Patients. Transplantation. 2021 10 01; 105(10):e146-e147.
Score: 0.243
-
Efficiency of a boost with a third dose of anti-SARS-CoV-2 messenger RNA-based vaccines in solid organ transplant recipients. Am J Transplant. 2022 01; 22(1):322-323.
Score: 0.241
-
High immunogenicity of a messenger RNA-based vaccine against SARS-CoV-2 in chronic dialysis patients. Nephrol Dial Transplant. 2021 08 27; 36(9):1704-1709.
Score: 0.241
-
Three Doses of an mRNA Covid-19 Vaccine in Solid-Organ Transplant Recipients. N Engl J Med. 2021 08 12; 385(7):661-662.
Score: 0.238
-
Kidney transplantation during the COVID-19 pandemic: Potential long-term consequences of an early post-transplant infection. Transpl Infect Dis. 2021 08; 23(4):e13446.
Score: 0.237
-
Acute rejection after anti-SARS-CoV-2 mRNA vaccination in a patient who underwent a kidney transplant. Kidney Int. 2021 07; 100(1):238-239.
Score: 0.236
-
Poor Anti-SARS-CoV-2 Humoral and T-cell Responses After 2 Injections of mRNA Vaccine in Kidney Transplant Recipients Treated With Belatacept. Transplantation. 2021 09 01; 105(9):e94-e95.
Score: 0.060
-
Adaptive lymphocyte profile analysis discriminates mild and severe forms of COVID-19 after solid organ transplantation. Kidney Int. 2021 10; 100(4):915-927.
Score: 0.059